Authors/Disclosures
|
No disclosure on file |
Stefan Nessler, MD
(University Medical Center Goettingen)
|
No disclosure on file |
Bernhard Hemmer, MD
(Technische Universität München)
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Shila Azodi, MD
(FOOD AND DRUG ADMINISTRATION)
|
Dr. Azodi has nothing to disclose. |
|
No disclosure on file |
Anne Gocke
|
No disclosure on file |
Amy E. Lovett Racke, PhD
(Ohio State University)
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Jeffrey L. Elliott, MD
(UT Southwestern Medical Center)
|
No disclosure on file |
|
No disclosure on file |
Petra Cravens, PhD
(UTSWMC)
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Michael K. Racke, MD
(Quest Diagnostics)
|
Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care. |
|
No disclosure on file |
Olaf Stuve, MD, PhD, FAAN
(UT Southwestern Medical Center)
|
Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA. |